Pharmacometabolomics Applied to Personalized Medicine in Urological Cancers

• Egile Nagusiak: Filipa Amaro (Egilea), Márcia Carvalho (Egilea), Maria de Lourdes Bastos (Egilea), Paula Guedes de Pinho (Egilea), Joana Pinto (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2022-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Prostate cancer (PCa), bladder cancer (BCa), and renal cell carcinoma (RCC) are the most common urological cancers, and their incidence has been rising over time. Surgery is the standard treatment for these cancers, but this procedure is only effective when the disease is localized. For metastatic d...